IBI354 With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer
Clinical trial NCT07377643 · RECRUITING
Trial details
- NCT number
- NCT07377643
- Sponsor
- Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-10
- Primary completion
- 2028-04-28
- Enrollment
- 540
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.